NCT00952120

Brief Summary

The purpose of this study is to compare how well two methods (VAC and G-SUC) of securing skin grafts using negative pressure wound therapy work. Negative pressure wound therapy is a commonly used method of applying suction on wounds to remove fluid from wound and to promote healing. The VAC system is widely used and consists of a foam dressing and a portable computerized suction pump. The G-SUC method uses commonly available dressing supplies attached to vacuum (suction) pump located on the wall above a hospital bed. The investigators have frequently used both methods over the past 10 years and have not observed any specific negative side effects of either.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started May 2009

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 31, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 4, 2009

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

September 24, 2015

Completed
Last Updated

September 24, 2015

Status Verified

August 1, 2015

Enrollment Period

2.6 years

First QC Date

July 31, 2009

Results QC Date

July 17, 2015

Last Update Submit

August 24, 2015

Conditions

Keywords

Wound healingNegative pressure wound therapySkin graft

Outcome Measures

Primary Outcomes (1)

  • Percentage of Wounds With Complete Skin Graft Take

    For each wound, the percentage of the skin graft that took by Day 4 or 5 was calculated. Complete take is defined as 100% take or skin graft incorporation.

    Day 4 or 5

Secondary Outcomes (1)

  • Percentage of Wounds With Total Skin Graft Loss

    Day 4 or 5

Study Arms (2)

GSUC

EXPERIMENTAL

Gauze-based wall suction negative pressure wound therapy for 4-5 days

Device: GSUC

Vacuum-assisted closure

ACTIVE COMPARATOR

Vacuum-assisted closure (VAC) negative pressure wound therapy using commercially available device (KCI, Inc) for 4-5 days

Device: VAC

Interventions

GSUCDEVICE

Gauze-based wall suction negative pressure wound therapy

GSUC
VACDEVICE

Commercially available Wound VAC negative pressure wound therapy device (KCI, Inc.)

Vacuum-assisted closure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients of any sex, hospitalized at the University of Chicago Medical Center, requiring split thickness skin autografts with wounds that are amenable to placement of an occlusive dressing for negative pressure therapy will be eligible to participate in the study

You may not qualify if:

  • Pregnant women, children under 18 years of age and other patients who are "vulnerable" as defined by the Institutional Review Board will not be eligible for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago Medical Center, Section of Plastic and Reconstructive Surgery

Chicago, Illinois, 60637, United States

Location

Results Point of Contact

Title
Lawrence Gottlieb
Organization
University of Chicago

Study Officials

  • Lawrence J Gottlieb, MD

    University of Chicago, Section of Plastic and Reconstructive Surgery

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2009

First Posted

August 4, 2009

Study Start

May 1, 2009

Primary Completion

December 1, 2011

Study Completion

July 1, 2012

Last Updated

September 24, 2015

Results First Posted

September 24, 2015

Record last verified: 2015-08

Locations